New York regulators have charged Omnium Canna with allegedly allowing unlicensed operators to manufacture and package cannabis under its license. The “rent-a-license” case exposes serious weaknesses in the state’s track-and-trace system and highlights why compliance and risk management are critical for cannabis operators.

Massachusetts cannabis advocates are fighting to keep the state’s $1.6 billion market alive as a repeal campaign gains momentum for the 2026 ballot. The outcome could redefine legalization not only in Massachusetts but across the country — and serve as a wake-up call for cannabis operators to prepare for regulatory risk.

A new lawsuit threatens to derail Florida’s adult-use cannabis initiative by challenging up to 200,000 voter signatures. As the state’s legalization campaign faces mounting legal and political hurdles, the future of recreational cannabis in Florida hangs in the balance.

Minnesota’s new cannabis retailers are facing empty shelves as supply chain bottlenecks and regulatory backlogs slow product delivery. Here’s why the shortages are happening, what lessons other states can offer, and how businesses can prepare for long-term stability.

A new synthetic cannabinoid shows strong potential in treating cachexia — the severe weight loss associated with cancer. This breakthrough could expand medical cannabis applications and reshape how cannabinoids are used in clinical care.

A federal judge in California temporarily blocked Perris from enforcing a cannabis billboard ban, ruling that the city failed to justify its restriction under the First Amendment. The case could set an important precedent for cannabis advertising rights and free commercial speech protections.

Ohio’s governor has issued a 90-day ban on intoxicating hemp-derived products, shaking up the state’s CBD and hemp market. The move highlights the growing push to regulate all THC products equally—and what businesses must do to adapt fast.

Ohio’s Senate has approved a major overhaul of marijuana DUI laws, requiring proof of actual impairment instead of relying on residual THC levels. The reform marks a shift toward science-based policy, setting a fairer and more accurate standard for cannabis enforcement.

Investor confidence is rising again as Canaccord Genuity turns bullish on U.S. cannabis stocks, citing optimism over rescheduling and federal reform. Here’s why this shift matters for operators, investors, and the broader cannabis industry.

Germany’s government has approved new restrictions on online cannabis prescriptions and deliveries, aiming to curb a surge in imports after legalization. The move reflects growing regulatory oversight in global cannabis markets and signals a new phase of compliance-driven expansion.

The VFW is partnering with Torch Beverage Company to sell hemp-derived THC seltzers across 27 states—marking a cultural shift in how cannabis is viewed by veterans and the mainstream. Proceeds will go toward supporting veterans in need, bridging wellness and advocacy through responsible cannabis use.

Kentucky just approved its second medical cannabis cultivator, signaling major progress for the state’s new program. This marks a turning point for southern cannabis markets—and a growing opportunity for early operators ready to enter responsibly.

San Francisco’s first cannabis equity dispensary was meant to symbolize fairness but instead ended in failure. Reports of City Hall insiders profiting highlight how equity programs can fall short, raising hard lessons for operators and investors alike.

The FDA has begun actively tracking adverse health events linked to hemp and CBD products. This new reporting process marks a step toward greater federal oversight and signals important changes ahead for operators, investors, and consumers.

Cannabis stocks rallied sharply after Donald Trump suggested Medicare could cover CBD in senior healthcare. While no policy has changed, the surge proves how political commentary still drives cannabis markets. Here’s what operators and investors can learn from this moment.

Breaking into New York’s cannabis market is no easy task. Silly Nice shows how quality, transparency, and bold branding can help cannabis businesses stand out and succeed in a crowded space.

Illegal cannabis grows are being shut down across California, highlighting the risks of non-compliance. Learn how licensed operators can protect their business with the right safeguards and insurance coverage.

Cannabis compliance is tightening as federal reform nears. From testing issues to OSHA and cGMP standards, businesses must adopt proactive strategies to stay competitive.